Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | NOW | CRM |
|---|---|---|
| Price | $137.78 | $238.22 |
| Change today | ▼ 2.13% | ▲ 0.27% |
| Market cap | $142.45B | $196.06B |
| Return, 3 months | +53.9% | +58.6% |
| Return, year to date | -10.1% | -9.6% |
| Return, 1 year | -25.0% | -0.5% |
| P/E (TTM) | 86.1 | 21.8 |
| P/B | 11.4 | 5.1 |
| P/E percentile vs own 5y | 26th | 9th |
| Dividend yield | – | 0.72% |
| Revenue growth (YoY, latest qtr) | +24.0% | +10.8% |
| Net profit growth (YoY) | -22.6% | +86.9% |
| Gross margin | 74.8% | 77.3% |
| Operating margin | 11.4% | 21.5% |
| Net margin | 11.3% | 22.0% |
| Return on equity | 14.2% | 19.4% |
| Analyst target vs. price | +3.2% | +15.9% |
| Analyst buy share | 90% | 76% |
| RSI (14) | 55 | 54 |
| 30-day volatility | 57.0% | 69.3% |
| Max drawdown, 1 year | -56.8% | -43.3% |
| Trend read | Leaning bullish | Leaning bullish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.